The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,180.00
Bid: 6,170.00
Ask: 6,200.00
Change: 160.00 (2.66%)
Spread: 30.00 (0.486%)
Open: 5,770.00
High: 6,190.00
Low: 5,770.00
Prev. Close: 6,020.00
FOUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison Investment Research Limited: 4imprint Group (FOUR) - Moving on up

1 Mar 2022 07:01

Edison Investment Research Limited Edison Investment Research Limited: 4imprint Group (FOUR) - Moving on up 01-March-2022 / 07:00 GMT/BST


 

London, UK, 1 March 2022

 

4imprint Group (FOUR) - Moving on up

4imprint's year-end trading update points to FY21 revenues of $787m, ahead of our expectation of $775m, up 41% on the prior year, after a strong Q4. PBT is indicated at the high end of the (wide) consensus range and we increase our estimate from $22.6m to $30.4m. Supply chain and inflation issues look set to continue, so margins will take longer to recover to the levels pre-COVID-19 pandemic, but the group has a degree of flexibility around substitution and pricing, which should mitigate the heaviest potential trading impact. 4imprint's long-term growth record, strong cash generation and robust balance sheet underpin the premium rating.

4imprint benefits from its scale, low fixed-cost base and limited capital requirements, attractive cash flow characteristics and cash positive balance sheet, all of which justify its premium rating. A DCF suggests a price of £33.29, while it trades on an FY22e EV/EBITDA of 21.5x, versus marketing services stocks on 10.5x. We expect continuing good growth will narrow this valuation gap.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Fiona Orford-Williams +44 (0)20 3077 5739 media@edisongroup.com

Max Hayes +44 (0)20 3077 5700 media@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1290081 01-March-2022 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
6th Jun 20229:25 amRNSEBT Purchase
24th May 20221:18 pmRNSResult of AGM
24th May 20227:00 amRNSAGM Statement and Notice of Results
17th May 20227:35 amRNSHolding(s) in Company
17th May 20227:34 amRNSHolding(s) in Company
16th May 20227:42 amRNSHolding(s) in Company
12th May 20222:00 pmRNSEBT Purchase
11th May 20229:11 amRNSHolding(s) in Company
9th May 20229:25 amRNSHolding(s) in Company
6th May 20227:00 amRNSTrading Statement
25th Apr 20228:51 amRNSHolding(s) in Company
22nd Apr 20223:40 pmRNSHolding(s) in Company
19th Apr 202210:03 amRNSAnnual Financial Report
8th Apr 20228:34 amRNSHolding(s) in Company
1st Apr 20228:13 amRNSHolding(s) in Company
21st Mar 20228:37 amRNSEBT Purchase
18th Mar 20229:36 amRNSHolding(s) in Company
16th Mar 20227:00 amRNSFinal Results
15th Mar 20222:56 pmRNSHolding(s) in Company
10th Mar 20221:22 pmRNSHolding(s) in Company
8th Mar 202210:21 amRNSHolding(s) in Company
1st Mar 20227:01 amEQSEdison Investment Research Limited: 4imprint Group (FOUR) - Moving on up
2nd Feb 20228:06 amRNSHolding(s) in Company
24th Jan 202211:58 amRNSHolding(s) in Company
21st Jan 20227:00 amRNSTrading Update and Notice of Final Results
8th Dec 20214:39 pmRNSHolding(s) in Company
7th Dec 20219:38 amRNSEBT Purchase
5th Nov 20217:00 amRNSTrading Update
12th Oct 20211:32 pmRNSEBT Purchase
17th Sep 20214:36 pmRNSPrice Monitoring Extension
14th Sep 20219:17 amRNSEBT Purchase
27th Aug 20212:43 pmRNSHolding(s) in Company
11th Aug 20217:00 amRNSHalf-year Report
10th Aug 20217:00 amRNSDirectorate Change
21st Jul 20218:20 amRNSHolding(s) in Company
25th Jun 20212:06 pmRNSHolding(s) in Company
18th Jun 20212:27 pmRNSHolding(s) in Company
18th May 202111:47 amRNSResult of AGM
18th May 20217:00 amRNSAGM Trading Statement and Notice of Results
5th May 20214:47 pmRNSEBT Purchase
20th Apr 202111:02 amRNSEBT Purchase
20th Apr 20218:35 amRNSDirector/PDMR Shareholding
16th Apr 20219:06 amRNSAnnual Financial Report
14th Apr 20219:25 amRNSHolding(s) in Company
14th Apr 20219:06 amRNSBoard Changes
22nd Mar 202110:24 amRNSDirector/PDMR Shareholding
19th Mar 20219:29 amRNSDirector/PDMR Shareholding
16th Mar 20217:00 amRNSFinal Results
10th Mar 20213:49 pmRNSDirector Declaration
25th Feb 20217:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.